Nystatin
NYSTATIN OINTMENT USP (100,000 units/g)
d7d04c02-d07d-4382-8f93-5c0c3e68790c
HUMAN PRESCRIPTION DRUG LABEL
Oct 1, 2022
Proficient Rx LP
DUNS: 079196022
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Nystatin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (2)
Drug Labeling Information
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Package/Label Display Panel
INDICATIONS & USAGE SECTION
INDICATIONS AND USAGE
Nystatin Ointment USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida (Monilia) albicans and other Candida species.
CONTRAINDICATIONS SECTION
CONTRAINDICATIONS
Nystatin Ointment USP is contraindicated in patients with a history of hypersensitivity to any of its components.
ADVERSE REACTIONS SECTION
ADVERSE REACTIONS
Nystatin is virtually nontoxic and nonsensitizing and is well tolerated by all age groups including debilitated infants, even on prolonged administration.
If irritation on topical application should occur, discontinue medication.
SPL UNCLASSIFIED SECTION
Rx Only
DESCRIPTION SECTION
DESCRIPTION
Each gram of Nystatin Ointment USP contains 100,000 units of nystatin in a white petrolatum base.
CLINICAL PHARMACOLOGY SECTION
CLINICAL PHARMACOLOGY
Nystatin is an antifungal antibiotic which is both fungistatic and fungicidal in vitro, against a wide variety of yeasts and yeast-like fungi. It probably acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is a polyene antibiotic of undetermined structural formula that is obtained from Streptomyces noursei, and is the first well tolerated antifungal antibiotic of dependable efficacy for the treatment of cutaneous, oral and intestinal infections caused by Candida (Monilia) albicans and other Candida species. It exhibits no appreciable activity against bacteria.
Nystatin provides specific therapy for all localized forms of candidiasis. Symptomatic relief is rapid, often occurring within 24 to 72 hours after the initiation of treatment. Cure is effected both clinically and mycologically in most cases of localized candidiasis.
PRECAUTIONS SECTION
PRECAUTIONS
Should a reaction of hypersensitivity occur the drug should be immediately withdrawn and appropriate measures taken.
DOSAGE & ADMINISTRATION SECTION
DOSAGE AND ADMINISTRATION
Nystatin Ointment USP should be applied liberally to the affected areas twice a day or as indicated until healing is complete. The ointment does not stain the skin or mucous membranes and it provides a simple, convenient means of treatment.
HOW SUPPLIED SECTION
HOW SUPPLIED
Nystatin Ointment USP 100,000 units/g
15 g tube (0**.**53 oz)
Store at controlled room temperature 15°-30°C (59°-86°F). Do not freeze.
Distributed by:
Actavis Pharma, Inc.
Parsippany, NJ 07054 USA
FORM NO. 0166
Rev. 10/19
VC2752
Relabeled By:
Proficient Rx LP
Thousand Oaks, CA 91320